Orforglipron Oral Tablets
Physician Consultation Fees are included in the monthly price. Click here to see the fees
- Lose weight without injections with Orforglipron, a next-generation oral GLP-1 therapy designed to curb appetite, support metabolic health, and promote sustainable weight loss.
Orforglipron is a next generation oral medication designed to support weight management and metabolic health without injections. This is a non-peptide GLP-1 receptor agonist that binds directly to GLP-1 receptors in the body to mimic the effects of the natural GLP-1 hormone and is specifically designed to be taken as a pill with more consistent absorption. Top benefits include appetite regulation, blood sugar control, and support consistent sustainable weight loss.
Indication: Used alongside a reduced-calorie diet and increased physical activity for adults with obesity or overweight with weight-related medical conditions.
Mechanism: Unlike peptide-based GLP-1s (like semaglutide), it is a small-molecule non-peptide that survives digestion.
Convenience: Taken once daily as a pill at any time of day, with no strict food, drink, or fasting rules.
Efficacy: Clinical trials showed an average weight loss ranging from roughly 7% to 11% (up to about 25 pounds) at 72 weeks depending on the dosage.
Orforglipron Oral Tablets Protocol:
- Patient will receive 3-months' worth of medication at a time (if approved). Protocol is ongoing, unless cancelled (Per our Terms of Service Policy)
- Patient will be billed monthly at $269 per month
- Patient agrees to our terms & conditions by purchasing the order
Weight Management Protocol Commitment - Weight management protocol requires a 90-day (3-month) commitment to allow adequate time for treatment evaluation and dose adjustments. Protocols are billed monthly during the initial 90-day commitment and cannot be cancelled during this period. After the initial 90 days, the protocol will automatically renew on a month-to-month basis. You may cancel anytime before your next billing date to avoid future charges.